{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:16:57Z","timestamp":1773022617868,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009560","name":"American Gastroenterological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009560","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ruesch Foundation"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA051008"],"award-info":[{"award-number":["CA051008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["TL1-TR001431"],"award-info":[{"award-number":["TL1-TR001431"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10620-019-05722-3","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T14:21:45Z","timestamp":1562854905000},"page":"189-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"65","author":[{"given":"Robin D.","family":"Tucker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Ciofoaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Nadella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha D.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Safronenka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan","family":"Shivapurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie J.","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander H. K.","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0835-4802","authenticated-orcid":false,"given":"Jill P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"5722_CR1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Akinyemiju T, Abera S, Ahmed M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3:1683\u20131691.","journal-title":"JAMA Oncol"},{"key":"5722_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123\u2013133.","journal-title":"Hepatology"},{"key":"5722_CR3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.metabol.2016.01.010","volume":"65","author":"H Zoller","year":"2016","unstructured":"Zoller H, Tilg H. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Metabolism. 2016;65:1151\u20131160.","journal-title":"Metabolism"},{"key":"5722_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","volume":"67","author":"A Marengo","year":"2016","unstructured":"Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 2016;67:103\u2013117.","journal-title":"Annu Rev Med"},{"key":"5722_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12876-015-0382-3","volume":"15","author":"MD Roberts","year":"2015","unstructured":"Roberts MD, Mobley CB, Toedebush RG, et al. Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown\u2013Norway rats. BMC Gastroenterol. 2015;15:151.","journal-title":"BMC Gastroenterol"},{"key":"5722_CR6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day CP, James OF. Steatohepatitis: a tale of two \u201chits\u201d? Gastroenterology. 1998;114:842\u2013845.","journal-title":"Gastroenterology"},{"key":"5722_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3748\/wjg.v25.i2.163","volume":"25","author":"N Tanaka","year":"2019","unstructured":"Tanaka N, Kimura T, Fujimori N, et al. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World J Gastroenterol. 2019;25:163\u2013177.","journal-title":"World J Gastroenterol"},{"key":"5722_CR8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","volume":"67","author":"SH Ibrahim","year":"2018","unstructured":"Ibrahim SH, Hirsova P, Gores GJ. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut. 2018;67:963\u2013972.","journal-title":"Gut"},{"key":"5722_CR9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u2013867.","journal-title":"Nature"},{"key":"5722_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","volume":"14","author":"S Mittal","year":"2016","unstructured":"Mittal S, El-Serag HB, Sada YH, et al. Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2016;14:124\u2013131.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5722_CR11","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1194\/jlr.R800053-JLR200","volume":"50","author":"CA Nagle","year":"2009","unstructured":"Nagle CA, Klett EL, Coleman RA. Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res. 2009;50:S74\u2013S79.","journal-title":"J Lipid Res"},{"key":"5722_CR12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA, Clark JM, Bass NM, et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology. 2010;52:913\u2013924.","journal-title":"Hepatology"},{"key":"5722_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/carcin\/bgx007","volume":"38","author":"G Brandi","year":"2017","unstructured":"Brandi G, De LS, Candela M, et al. Microbiota, NASH, HCC and the potential role of probiotics. Carcinogenesis. 2017;38:231\u2013240.","journal-title":"Carcinogenesis"},{"key":"5722_CR14","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","volume":"150","author":"QM Anstee","year":"2016","unstructured":"Anstee QM, Seth D, Day CP. Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease. Gastroenterology. 2016;150:1728\u20131744.","journal-title":"Gastroenterology"},{"key":"5722_CR15","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/ijms17091575","volume":"17","author":"A Caligiuri","year":"2016","unstructured":"Caligiuri A, Gentilini A, Marra F. Molecular pathogenesis of NASH. Int J Mol Sci. 2016;17:1575.","journal-title":"Int J Mol Sci"},{"key":"5722_CR16","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","volume":"48","author":"O Cheung","year":"2008","unstructured":"Cheung O, Puri P, Eicken C, et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology. 2008;48:1810\u20131820.","journal-title":"Hepatology"},{"key":"5722_CR17","doi-asserted-by":"crossref","first-page":"e2916","DOI":"10.1038\/cddis.2017.309","volume":"8","author":"L Cheng","year":"2017","unstructured":"Cheng L, Zhu Y, Han H, et al. MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice. Cell Death Dis. 2017;8:e2916.","journal-title":"Cell Death Dis"},{"key":"5722_CR18","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3892\/ijo.2014.2373","volume":"44","author":"X-R Long","year":"2014","unstructured":"Long X-R, He Y, Huang C, et al. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis. Int J Oncol. 2014;44:1915\u20131922.","journal-title":"Int J Oncol"},{"key":"5722_CR19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/carcin\/bgy141","volume":"40","author":"KB Pedersen","year":"2019","unstructured":"Pedersen KB, Pulliam CF, Patel A, et al. Liver tumorigenesis is promoted by a high saturated-fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus. Carcinogenesis. 2019;40:349\u2013359.","journal-title":"Carcinogenesis"},{"key":"5722_CR20","first-page":"9","volume":"54","author":"GJ Dockray","year":"2003","unstructured":"Dockray GJ. Luminal sensing in the gut: an overview. J Physiol Pharmacol. 2003;54:9\u201317.","journal-title":"J Physiol Pharmacol"},{"key":"5722_CR21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0016-5085(99)70227-1","volume":"116","author":"J McLaughlin","year":"1999","unstructured":"McLaughlin J, Grazia LM, Jones MN, et al. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology. 1999;116:46\u201353.","journal-title":"Gastroenterology"},{"key":"5722_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.peptides.2015.09.010","volume":"77","author":"C Gibbons","year":"2016","unstructured":"Gibbons C, Finlayson G, Caudwell P, et al. Postprandial profiles of CCK after high fat and high carbohydrate meals and the relationship to satiety in humans. Peptides. 2016;77:3\u20138.","journal-title":"Peptides"},{"key":"5722_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s10620-014-3201-8","volume":"59","author":"GL Matters","year":"2014","unstructured":"Matters GL, Cooper TK, McGovern CO, et al. Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. Dig Dis Sci. 2014;59:1180\u20131191. https:\/\/doi.org\/10.1007\/s10620-014-3201-8.","journal-title":"Dig Dis Sci"},{"key":"5722_CR24","doi-asserted-by":"crossref","first-page":"G699","DOI":"10.1152\/ajpgi.00123.2018","volume":"315","author":"S Nadella","year":"2018","unstructured":"Nadella S, Burks J, Al-Sabban A, et al. Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor. Am J Physiol Gastrointest Liver Physiol. 2018;315:G699\u2013G712.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5722_CR25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1152\/physrev.00014.2005","volume":"86","author":"M Dufresne","year":"2006","unstructured":"Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev. 2006;86:805\u2013847.","journal-title":"Physiol Rev"},{"key":"5722_CR26","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1073\/pnas.89.18.8691","volume":"89","author":"SA Wank","year":"1992","unstructured":"Wank SA, Pisegna JR, de Weerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci U S A. 1992;89:8691\u20138695.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5722_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.1994.tb44052.x","volume":"713","author":"SA Wank","year":"1994","unstructured":"Wank SA, Pisegna JR, de Weerth A. Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human. Ann N Y Acad Sci. 1994;713:49\u201366.","journal-title":"Ann N Y Acad Sci"},{"key":"5722_CR28","first-page":"R277","volume":"266","author":"JP Smith","year":"1994","unstructured":"Smith JP, Liu G, Soundararajan V, et al. Identification and characterization of CCK-B\/gastrin receptors in human pancreatic cancer cell lines. Am J Physiol. 1994;266:R277\u2013R283.","journal-title":"Am J Physiol"},{"key":"5722_CR29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/gut.42.6.795","volume":"42","author":"DF McWilliams","year":"1998","unstructured":"McWilliams DF, Watson SA, Crosbee DM, et al. Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut. 1998;42:795\u2013798.","journal-title":"Gut"},{"key":"5722_CR30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcmgh.2017.03.004","volume":"4","author":"JP Smith","year":"2017","unstructured":"Smith JP, Nadella S, Osborne N. Gastrin and gastric cancer. Cell Mol Gastroenterol Hepatol. 2017;4:75\u201383.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5722_CR31","first-page":"411","volume":"12","author":"JP Smith","year":"1998","unstructured":"Smith JP, Shih AH, Wotring MG, et al. Characterization of CCK-B\/gastrin-like receptors in human gastric carcinoma. Int J Oncol. 1998;12:411\u2013419.","journal-title":"Int J Oncol"},{"key":"5722_CR32","first-page":"1612","volume":"46","author":"P Singh","year":"1986","unstructured":"Singh P, Walker JP, Townsend CM Jr, et al. Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB\/c mice. Cancer Res. 1986;46:1612\u20131616.","journal-title":"Cancer Res"},{"key":"5722_CR33","first-page":"R797","volume":"271","author":"JP Smith","year":"1996","unstructured":"Smith JP, Stock EA, Wotring MG, et al. Characterization of the CCK-B\/gastrin-like receptor in human colon cancer. Am J Physiol. 1996;271:R797\u2013R805.","journal-title":"Am J Physiol"},{"key":"5722_CR34","doi-asserted-by":"crossref","first-page":"14605","DOI":"10.18632\/oncotarget.7522","volume":"7","author":"J Roy","year":"2016","unstructured":"Roy J, Putt KS, Coppola D, et al. Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. Oncotarget. 2016;7:14605\u201314615.","journal-title":"Oncotarget"},{"key":"5722_CR35","doi-asserted-by":"crossref","first-page":"e20687","DOI":"10.1371\/journal.pone.0020687","volume":"6","author":"JJ LaConti","year":"2011","unstructured":"LaConti JJ, Shivapurkar N, Preet A, et al. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS ONE. 2011;6:e20687.","journal-title":"PLoS ONE"},{"key":"5722_CR36","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/MPA.0000000000000194","volume":"43","author":"JP Smith","year":"2014","unstructured":"Smith JP, Cooper TK, McGovern CO, et al. Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice. Pancreas. 2014;43:1050\u20131059.","journal-title":"Pancreas"},{"key":"5722_CR37","doi-asserted-by":"crossref","first-page":"e0158961","DOI":"10.1371\/journal.pone.0158961","volume":"11","author":"B Yu","year":"2016","unstructured":"Yu B, Lv X, Su L, et al. MiR-148a functions as a tumor suppressor by targeting CCK-BR via inactivating STAT3 and Akt in human gastric cancer. PLoS ONE. 2016;11:e0158961.","journal-title":"PLoS ONE"},{"key":"5722_CR38","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2174\/156802607780960519","volume":"7","author":"MJ Berna","year":"2007","unstructured":"Berna MJ, Jensen RT. Role of CCK\/gastrin receptors in gastrointestinal\/metabolic diseases and results of human studies using gastrin\/CCK receptor agonists\/antagonists in these diseases. Curr Top Med Chem. 2007;7:1211\u20131231.","journal-title":"Curr Top Med Chem"},{"key":"5722_CR39","first-page":"314","volume":"26","author":"SE Miederer","year":"1979","unstructured":"Miederer SE, Lindstaedt H, Kutz K, et al. Efficient treatment of gastric ulcer with proglumide (Milid) in outpatients (double blind trial). Acta Hepatogastroenterol (Stuttg). 1979;26:314\u2013318.","journal-title":"Acta Hepatogastroenterol (Stuttg)"},{"key":"5722_CR40","doi-asserted-by":"crossref","first-page":"38905","DOI":"10.1074\/jbc.M110.125534","volume":"285","author":"MJ Berna","year":"2010","unstructured":"Berna MJ, Seiz O, Nast JF, et al. CCK1 and CCK2 receptors are expressed on pancreatic stellate cells and induce collagen production. J Biol Chem. 2010;285:38905\u201338914.","journal-title":"J Biol Chem"},{"key":"5722_CR41","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1074\/jbc.270.15.8429","volume":"270","author":"P Singh","year":"1995","unstructured":"Singh P, Owlia A, Espeijo R, et al. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors. J Biol Chem. 1995;270:8429\u20138438.","journal-title":"J Biol Chem"},{"key":"5722_CR42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00262-017-2077-9","volume":"67","author":"JP Smith","year":"2018","unstructured":"Smith JP, Wang S, Nadella S, et al. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother. 2018;67:195\u2013207.","journal-title":"Cancer Immunol Immunother"},{"key":"5722_CR43","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1126\/science.1161431","volume":"322","author":"KS Zaret","year":"2008","unstructured":"Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science. 2008;322:1490\u20131494.","journal-title":"Science"},{"key":"5722_CR44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","volume":"241","author":"JK Lau","year":"2017","unstructured":"Lau JK, Zhang X, Yu J. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. J Pathol. 2017;241:36\u201344.","journal-title":"J Pathol"},{"key":"5722_CR45","doi-asserted-by":"crossref","first-page":"e53992","DOI":"10.1371\/journal.pone.0053992","volume":"8","author":"L Ochoa-Callejero","year":"2013","unstructured":"Ochoa-Callejero L, Perez-Martinez L, Rubio-Mediavilla S, et al. Maraviroc, a CCR46 antagonist, prevents development of hepatocellular carcinoma in a mouse model. PLoS ONE. 2013;8:e53992.","journal-title":"PLoS ONE"},{"key":"5722_CR46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1017\/S0954422415000128","volume":"28","author":"DT Reid","year":"2015","unstructured":"Reid DT, Eksteen B. Murine models provide insight to the development of non-alcoholic fatty liver disease. Nutr Res Rev. 2015;28:133\u2013142.","journal-title":"Nutr Res Rev"},{"key":"5722_CR47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jceh.2015.06.004","volume":"5","author":"S Iyer","year":"2015","unstructured":"Iyer S, Upadhyay PK, Majumdar SS, et al. Animal models correlating immune cells for the development of NAFLD\/NASH. J Clin Exp Hepatol. 2015;5:239\u2013245.","journal-title":"J Clin Exp Hepatol"},{"key":"5722_CR48","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/1940-6207.CAPR-13-0065","volume":"6","author":"DW Dawson","year":"2013","unstructured":"Dawson DW, Hertzer K, Moro A, et al. High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D Mouse model. Cancer Prev Res (Phila). 2013;6:1064\u20131073.","journal-title":"Cancer Prev Res (Phila)"},{"key":"5722_CR49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.1840030118","volume":"3","author":"TR Perez","year":"1983","unstructured":"Perez TR. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology. 1983;3:112\u2013120.","journal-title":"Hepatology"},{"key":"5722_CR50","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.3390\/nu7105423","volume":"7","author":"TF Tzeng","year":"2015","unstructured":"Tzeng TF, Tzeng YC, Cheng YJ, et al. The ethanol extract from Lonicera japonica Thunb. regresses nonalcoholic steatohepatitis in a methionine- and choline-deficient diet-fed animal model. Nutrients. 2015;7:8670\u20138684.","journal-title":"Nutrients"},{"key":"5722_CR51","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.ajpath.2016.03.005","volume":"186","author":"J Kohn-Gaone","year":"2016","unstructured":"Kohn-Gaone J, Dwyer BJ, Grzelak CA, et al. Divergent inflammatory, fibrogenic, and liver progenitor cell dynamics in two common mouse models of chronic liver injury. Am J Pathol. 2016;186:1762\u20131774.","journal-title":"Am J Pathol"},{"key":"5722_CR52","first-page":"1635","volume":"8","author":"AM Passman","year":"2015","unstructured":"Passman AM, Strauss RP, McSpadden SB, et al. A modified choline-deficient, ethionine-supplemented diet reduces morbidity and retains a liver progenitor cell response in mice. Dis Model Mech. 2015;8:1635\u20131641.","journal-title":"Dis Model Mech"},{"key":"5722_CR53","doi-asserted-by":"crossref","first-page":"e0171215","DOI":"10.1371\/journal.pone.0171215","volume":"12","author":"B Lacoste","year":"2017","unstructured":"Lacoste B, Raymond VA, Cassim S, et al. Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties. PLoS ONE. 2017;12:e0171215.","journal-title":"PLoS ONE"},{"key":"5722_CR54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402\u2013408.","journal-title":"Methods"},{"key":"5722_CR55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fob.2013.12.001","volume":"4","author":"FM Keane","year":"2013","unstructured":"Keane FM, Yao TW, Seelk S, et al. Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Biol. 2013;4:43\u201354.","journal-title":"FEBS Open Biol"},{"key":"5722_CR56","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675\u20131685.","journal-title":"N Engl J Med"},{"key":"5722_CR57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2036.2011.04912.x","volume":"35","author":"E Boettcher","year":"2012","unstructured":"Boettcher E, Csako G, Pucino F, et al. Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2012;35:66\u201375.","journal-title":"Aliment Pharmacol Ther"},{"key":"5722_CR58","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2001-17556","volume":"21","author":"D Schuppan","year":"2001","unstructured":"Schuppan D, Ruehl M, Somasundaram R, et al. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis. 2001;21:351\u2013372.","journal-title":"Semin Liver Dis"},{"key":"5722_CR59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00441-009-0844-4","volume":"339","author":"MK Gordon","year":"2010","unstructured":"Gordon MK, Hahn RA. Collagens. Cell Tissue Res. 2010;339:247\u2013257.","journal-title":"Cell Tissue Res"},{"key":"5722_CR60","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/00365529409096841","volume":"29","author":"K Yabu","year":"1994","unstructured":"Yabu K, Kiyosawa K, Mori H, et al. Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C. Scand J Gastroenterol. 1994;29:474\u2013479.","journal-title":"Scand J Gastroenterol"},{"key":"5722_CR61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4161\/cbt.13.3.18696","volume":"13","author":"R Liu","year":"2012","unstructured":"Liu R, Li H, Liu L, et al. Fibroblast activation protein: a potential therapeutic target in cancer. Cancer Biol Ther. 2012;13:123\u2013129.","journal-title":"Cancer Biol Ther"},{"key":"5722_CR62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/carcin\/5.8.989","volume":"5","author":"N Shivapurkar","year":"1984","unstructured":"Shivapurkar N, Wilson MJ, Poirier LA. Hypomethylation of DNA in ethionine-fed rats. Carcinogenesis. 1984;5:989\u2013992.","journal-title":"Carcinogenesis"},{"key":"5722_CR63","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jhep.2013.07.026","volume":"59","author":"K Chaudhary","year":"2013","unstructured":"Chaudhary K, Liedtke C, Wertenbruch S, et al. Caspase 8 differentially controls hepatocytes and non-parenchymal liver cells during chronic cholestatic liver injury in mice. J Hepatol. 2013;59:1292\u20131298.","journal-title":"J Hepatol"},{"key":"5722_CR64","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1007\/BF02088134","volume":"39","author":"K Sztefko","year":"1994","unstructured":"Sztefko K, Li P, Ballatori N, et al. CCK-receptor antagonists proglumide and loxiglumide stimulate bile flow and biliary glutathione excretion. Dig Dis Sci. 1994;39:1974\u20131980. https:\/\/doi.org\/10.1007\/BF02088134.","journal-title":"Dig Dis Sci"},{"key":"5722_CR65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/path.4580","volume":"237","author":"Y Chen","year":"2015","unstructured":"Chen Y, Guldiken N, Spurny M, et al. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction. J Pathol. 2015;237:343\u2013354.","journal-title":"J Pathol"},{"key":"5722_CR66","first-page":"325","volume":"22","author":"JG Pauletzki","year":"1995","unstructured":"Pauletzki JG, Xu QW, Shaffer EA. Inhibition of gallbladder emptying decreases cholesterol saturation in bile in the Richardson ground squirrel. Hepatology. 1995;22:325\u2013331.","journal-title":"Hepatology"},{"key":"5722_CR67","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/ijo.2009.9","volume":"33","author":"TH Moran","year":"2009","unstructured":"Moran TH. Gut peptides in the control of food intake. Int J Obes (Lond). 2009;33:S7\u201310.","journal-title":"Int J Obes (Lond)"},{"key":"5722_CR68","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/pr.2014.202","volume":"77","author":"SC Ferrante","year":"2015","unstructured":"Ferrante SC, Nadler EP, Pillai DK, et al. Adipocyte-derived exosomal miRNAs: a novel mechanism for obesity-related disease. Pediatr Res. 2015;77:447\u2013454.","journal-title":"Pediatr Res"},{"key":"5722_CR69","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1038\/srep09930","volume":"5","author":"C Shi","year":"2015","unstructured":"Shi C, Zhang M, Tong M, et al. miR-148a is Associated with Obesity and Modulates Adipocyte Differentiation of Mesenchymal Stem Cells through Wnt Signaling. Sci Rep. 2015;5:9930.","journal-title":"Sci Rep"},{"key":"5722_CR70","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/apm.12389","volume":"123","author":"L Wu","year":"2015","unstructured":"Wu L, Dai X, Zhan J, et al. Profiling peripheral microRNAs in obesity and type 2 diabetes mellitus. APMIS. 2015;123:580\u2013585.","journal-title":"APMIS"},{"key":"5722_CR71","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00335-009-9217-2","volume":"20","author":"E Zhao","year":"2009","unstructured":"Zhao E, Keller MP, Rabaglia ME, et al. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome. 2009;20:476\u2013485.","journal-title":"Mamm Genome"},{"key":"5722_CR72","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1039\/C4MB00563E","volume":"11","author":"XX He","year":"2015","unstructured":"He XX, Kuang SZ, Liao JZ, et al. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. Mol Biosyst. 2015;11:532\u2013539.","journal-title":"Mol Biosyst"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05722-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-019-05722-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05722-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:21:07Z","timestamp":1744176067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-019-05722-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5722"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05722-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Jill P. Smith has intellectual property on the use of CCK receptor antagonists in NASH. Sandeep Nadella and Jill P. Smith are co-inventors on a pending patent for proglumide and fibrosis. None of the other authors have conflicts to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}